US PATENT: Mycoplasma arthritidis mitogen | Arthritis Information

Share
 

Mycoplasma arthritidis T-cell mitogen

Online Reference; http://www.freepatentsonline.com/5872233.html

United States Patent 5872233

A method of purifying Mycoplasma arthritidis mitogen (MAM) to electrophoretic and sequence homogeneity is disclosed. A preparation of MAM purified according to this method was used to determine the sequence of the N-terminal 54 amino acids of MAM. A synthetic peptide consisting of amino acids 15-32 inhibited MAM-induced cell proliferation in vitro. The sequence of the N-terminal 54 amino acids was reverse translated, nucleotide probes were designed therefrom, and the MAM gene was selected from a genomic library. The MAM gene was sequenced and found to be contained on a 1107 bp DNA fragment. The primary translation product contains a 39 amino acid signal sequence and a 213 amino acid mature MAM (molecular weight 25,294). Amino acid sequence comparisons of MAM to bacterial and murine tumor virus superantigens showed regions of conservative sequence homology, including the region capable of inhibiting cell proliferation. Sequence homologies to HIV and other retrovirus proteins and to certain regulatory proteins were also detected. Strategies for blocking or immunizing against certain diseases, including autoimmune diseases, are disclosed.

------------------------------------------------------------------------------------------------


Synopses

 

Mycoplasmas: Sophisticated, Reemerging, and Burdened by Their Notoriety

 

Joel B. Baseman* and Joseph G. Tully†

*The University of Texas Health Science Center at San Antonio, San Antonio,

Texas, USA; †National Institute of Allergy and Infectious Diseases,

Frederick Cancer Research and Development Center, Frederick, Maryland, USA

(Emerging Infectious Diseases
National Center for Infectious Diseases

Centers for Disease Control and Prevention Atlanta, GA)

*****(BELOW IS AN EXCERPT FROM THIS DOCUMENT)

Rheumatoid Arthritis and Other Human Arthritides

The occurrence of various Mycoplasma and Ureaplasma species in joint

tissues of patients with rheumatoid arthritis,...........and other human arthritides can no longer be ignored

(8). A clinical trial of longterm (6 to 12 months) antibiotic (doxycycline)

therapy before cartilage destruction might prove beneficial in managing

such frequent and often debilitating infections.

----------------------------------------------------------------------------------------------

Detection of mycoplasmal infections in blood of patients with rheumatoid arthritis.
J. Haier, M. Nasralla, A. R. Franco1 and G. L. Nicolson ...

http://rheumatology.oxfordjournals.org/content/38/6/504.full.pdf

----------------------------------------------------------------------------------------------------------------

Immunology. 2008 Feb;123(2):187-96. Epub 2007 Aug 4.

The importance of B-cells and ecto-5'nucleotidase in Mycoplasma fermentans infection and the relevance to rheumatoid arthritis.

Johnson SM.

------------------------------------------------------------------------------------------------------------------